背景:整形外科是复发性医疗事故索赔风险最高的医学专业之一。民事诉讼的频率代表了这些健康治疗从业者的微观和宏观经济的问题。本文旨在讨论与手术错误相关但由于甲状腺功能亢进症而导致的眼睑整容术并发眼睑的情况下的医学法律方面和索赔路径。
背景:一名48岁女性因未确诊的甲状腺功能亢进而接受了眼睑整容术,声称手术后几个月发生的眼角是由于医疗事故,由于过度切除了旺盛的下眼睑组织。审查的问题是,“甲状腺功能障碍通常被视为禁忌症吗?”和通过PubMed的MEDLINE数据库,Embase,Scopus,奥维德,ISIWebofScience,科克伦,和谷歌学者被使用。
结论:有21篇合格论文。该案例强调了因果推断的重要性和复杂性(例如未知的甲状腺功能障碍),相关知情同意,涉及与渎职无关的可能并发症的信息,和指南建议对有风险的患者进行美容/功能性眼睑成形术的内分泌咨询(例如,已知甲状腺疾病史的女性患者)。
BACKGROUND: Plastic surgery is one of the medical specialties with the highest risk of recurrent medical malpractice claims. The frequency of civil lawsuits represents an issue for the micro- and macro-economy of practitioners of these health treatments. This paper aims to discuss the medico-legal aspects and claim path in a
case of a cosmetic
blepharoplasty complicated by lagophthalmos wrongly related to the procedure but due to missed hyperthyroidism.
BACKGROUND: A 48-year-old woman who underwent cosmetic
blepharoplasty with undiagnosed hyperthyroidism claimed that the lagophthalmos that occurred some months after the procedure was due to medical malpractice, due to an over-resection of the exuberant lower eyelid tissue. The review question was, \"Are thyroid disfunctions usually considered contraindications to be communicated to patients who undergo
blepharoplasty?\", and the databases MEDLINE via PubMed, Embase, Scopus, Ovid, ISI Web of Science, Cochrane, and Google Scholar were used.
CONCLUSIONS: There were 21 eligible papers. The
case highlights the importance and complexity of causal inference (such as unknown thyroid dysfunctions), related informed consent involving information on possible complications unrelated to malpractice, and guidelines recommending endocrinological consultation for cosmetic/functional
blepharoplasty in patients at risk (e.g., female patients with a known history of thyroid disease).